To commemorate the 60th anniversary of the peak of the entrepreneurial essay, calligraphy and painting photography exhibition selection announced
Release time:
2020-07-30
News from our newspaper On the occasion of the celebration of the 5th anniversary of the start-up of the peak 60#, the selection results of the "I and the peak" essay and the staff calligraphy and painting photography exhibition were also newly released.
Commemorates the 11th Anniversary of Peak Venture 60# "Me and Peak" Essay Campaign Since 2017 7 , more than 50 contributions have been received from employees and their families of various enterprises. According to the overall situation of the content and writing level of the essay, the first prize works 3 , the second prize works 5 and the third prize works 7 were selected.
Staff Calligraphy and Photography Exhibition 4 started soliciting contributions in early September. In just five months, it received more than 100 works from dozens of authors from various enterprises under the group. The exhibition was successfully held on 10 10 -17 , which was welcomed and praised by the majority of employees. After a comprehensive selection of employees' contributions, a total of 3 first-class works, 5 second-class works and 7 third-class works were selected.
In order to ensure the fairness and impartiality of the selection, the works of the leading group, members of the working group and specially invited works to commemorate the 49th anniversary of the peak entrepreneurship 60# will not participate in the selection of the grade award. (The list of winners is attached) (This reporter)
first prize
"mother and son deep love"
author: daye Peak Stone Rich "I Have an Appointment with Peak"
Author: Yunnan Peak Luo Meiyan "Buying a House"
Author: peak Cable Lu Chaofang Second Prize
"Ten Years and Sixty Years"
Author: Pharmaceutical Sales Company Xu Yuting "My Peak Road"
Author: daye Peak Yang Zhendong "My Teacher"
Author: City Pharmaceutical Company Fan Tufa "Peak Grows with Me for 20 Years"
Author: Pharmaceutical Sales Company Xu Junxiong "Peak Grows with Me"
Author: staff Family Zhu Yanjun Third Prize
"My Experience of" Acoustics "
Author: Daye Peak Zhu Yong " Memories of Past "
Author: qiubin Factory Wang Haibin " I'm a Store Manager at Peak "
Author: Peak Pharmacy Tong Yanran " I'm predestined friends with Peak "
Author: jin Xi Chang Yang Ming " Our Growth "
Author: Yunnan Jianfeng Shang Yongzhen " This Peace of Heart is My Hometown "
Author: peak Health Bao Jieming " Across the Edge of
km "Author: peak Health Wang Bingbing
First Prize
Calligraphy" Avenue to Far Sea and Include All Rivers "
Author: Peak Health Wang Jianhua Traditional Chinese Painting" Hongyan "
Author: retired Worker Yu Sister Photography" Hanging Up "
Author: Yunnan Jianfeng Fang Xuhua Second Prize
Calligraphy" Return "
Author: Municipal Pharmaceutical Company Yuan Su Hard Pen Calligraphy" Lanting Collection Preface "
Author: fan Tufa Traditional Chinese Painting" Luming Youyou Pine Wind Far "
Author: Peak Health Xu Peak Photography" Happy Work "
Author: Pharmaceutical Sales Company Wang Hongfeng Photography" Time "
Author: retired employee Chen Shu Third Prize
Calligraphy" Chunxiao "
Author: Lu Lianming Calligraphy" Centennial Peak "
Author: Cable Company Qian Fang Oil Painting "Sending and Blooming"
Author: Peak Health King Chao Photography "Interesting"
Author: Group Headquarters Xu Xia Photography "Spring Snow"
Author: tianjin Jianfeng Flanders Liu Hairong Photography "Still Holding Pipa"
Author: Jianfeng Health Chen Lisa Photography "Nap"
Author: Jianfeng Health Zhou Guangliang
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page